Novel biological and clinical aspects of thyroid hormone metabolism

Endocrine Development

Volumn 10, Issue , 2007, Pages 127-139

  Dumitrescu, A ^a   Refetoff, S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE PEROXIDASE; ISOENZYME; RNA BINDING PROTEIN; SECISBP2 PROTEIN, HUMAN; SELENOPROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; REVIEW; THYROID DISEASE;

ANIMALS; HUMANS; IODIDE PEROXIDASE; ISOENZYMES; MICE; MICE, KNOCKOUT; MUTATION; RNA-BINDING PROTEINS; SELENOPROTEINS; THYROID DISEASES; THYROID HORMONES;

EID: 35148896480     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000106824     Document Type: Review

References (30)

1. Friesema EC, Jansen J, Milici C, Visser TJ: Thyroid hormone transporters. Vitam Horm 2005;70:137-167.
2. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23:38-89.
3. Refetoff S, Dumont JE, Vassart G: Thyroid disorders; in Scriver CR (ed): The Metabolic and Molecular Bases of Inherited Diseases. New York, McGraw Hill, 2001, chap 158.
4. Driscoll DM, Copeland PR: Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr 2003;23:17-40.
5. Hatfield DL, Gladyshev VN: How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002;22:3565-3576.
6. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM: A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. EMBO J 2000;19:306-314.
7. Dumitrescu AM, Liao XH, Abdullah MS, et al: Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005;37:1247-1252.
8. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S: A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168-175.
9. Friesema EC, Grueters A, Biebermann H, et al: Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004;364:1435-1437.
10. Botero D, Gereben B, Goncalves C, et al: Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. Mol Endocrinol 2002;16:1999-2007.
11. Curcio-Morelli C, Zavacki AM, Christofollete M, et al: Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J Clin Invest 2003;112:189-196.
12. Lescure A, Allmang C, Yamada K, Carbon P, Krol A: cDNA cloning, expression pattern and RNA binding analysis of human selenocysteine insertion sequence (SECIS) binding protein 2. Gene 2002;291:279-285.
13. Copeland PR: Regulation of gene expression by stop codon recoding: selenocysteine. Gene 2003;312:17-25.
14. Kohrle J: Selenium and the control of thyroid hormone metabolism. Thyroid 2005;15:841-853.
15. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S: Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006;147:4036-4043.
16. Umpierrez GE: Euthyroid sick syndrome. South Med J 2002;95:506-513.
17. Huang SA, Tu HM, Harney JW, et al: Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000;343:185-189.
18. Schneider MJ, Fiering SN, Thai B, et al: Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 2006;147:580-589.
19. Maia AL, Berry MJ, Sabbag R, Harney JW, Larsen PR: Structural and functional differences in the dio1 gene in mice with inherited type 1 deiodinase deficiency. Mol Endocrinol 1995;9:969-980.
20. Schneider MJ, Fiering SN, Pallud SE, et al: Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 2001;15:2137-2148.
21. Ng L, Goodyear RJ, Woods CA, et al: Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci USA 2004;101:3474-3479.
22. Christoffolete MA, Arrojo EDR, Gazoni F, et al: Mice with impaired extrathyroidal thyroxine to 3,5,3′-triiodothyronine (T3) conversion maintain normal serum T3 concentrations. Endocrinology 2007;148:954-960.
23. Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D: The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology 2002;143:4483-4486.
24. Schomburg L, Schweizer U, Kohrle J: Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 2004;61:1988-1995.
25. Bosl MR, Takaku K, Oshima M, Nishimura S, Taketo MM: Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci USA 1997;94:5531-5534.
26. Schweizer U, Schomburg L, Savaskan NE: The neurobiology of selenium: lessons from transgenic mice. J Nutr 2004;134:707-710.
27. SerSec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 2004;279:8011-8017.
28. Carlson BA, Xu XM, Gladyshev VN, Hatfield DL: Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem 2005;280:5542-5548.
29. Weiss Sachdev S, Sunde RA: Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem J 2001;357:851-858.
30. Chu FF, Esworthy RS, Chu PG, et al: Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 2004;64:962-968.